FY26
Assets1,780.79
Net Worth1,149.59
Total Debt387.91
RevenueAnnualised basis869.14
EBITDAAnnualised basis231.97
PATAnnualised basis109.90
EBITDA Margin (%)26.69
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Assets989.99₹ Cr · -23.5% vs prior year
Net Worth621.44₹ Cr · -13.1% vs prior year
FY25
Assets1,579.65
Net Worth814.71
Total Debt540.92
RevenueAnnualised basis751.55
EBITDAAnnualised basis206.11
PATAnnualised basis96.78
EBITDA Margin (%)27.42
FY24
Assets1,294.78
Net Worth714.84
Total Debt247.20
RevenueAnnualised basis716.25
EBITDAAnnualised basis177.04
PATAnnualised basis100.05
EBITDA Margin (%)24.72
FY23
Assets989.99
Net Worth621.44
Total Debt217.87
RevenueAnnualised basis566.15
EBITDAAnnualised basis74.25
PATAnnualised basis23.49
EBITDA Margin (%)13.11
IPO UPDATE ALERTS
Register for IPO Updates →Track Symbiotec Pharmalab without missing an update
Register for subscription, GMP, allotment and listing notifications.